Clover Health Investments (FRA:7QD) Payments of Debt: €0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:7QD Clover Health Investments Corp FRA:7QD
83 GF Score
Price €3.90
GF Value €3.67
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Clover Health Investments Payments of Debt?

Clover Health Investments FRA:7QD -2.50% 83 Payments of Debt is €0 Mil as of Mar. 2026. GuruFocus rates FRA:7QD with a GF Score™ of 83/100 and a GF Value™ of €3.67 (Fairly Valued). The stock has 3 warning signs investors should review.

Clover Health Investments's Payments of Debt for the three months ended in Mar. 2026 was €0 Mil.

Clover Health Investments's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was €0 Mil.

Clover Health Investments Payments of Debt Related Terms

Clover Health Investments Payments of Debt Historical Data

* Premium members only.

The historical data trend for Clover Health Investments's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clover Health Investments Payments of Debt Chart

Clover Health Investments Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Payments of Debt
Get a 7-Day Free Trial -27.37 0.00 0.00 0.00 0.00

Clover Health Investments Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:7QD
83GF Score
Clover Health Investments Corp FRA:7QD
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clover Health Investments Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of €0 Mil mean?
Clover Health Investments (FRA:7QD) has a Payments of Debt of €0 Mil as of Mar. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Clover Health Investments and its competitors.
Is Clover Health Investments' Payments of Debt too high?
Clover Health Investments' current Payments of Debt is €0 Mil. Overall, Clover Health Investments has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Clover Health Investments' Payments of Debt compare to PGNY and ALHC?
Clover Health Investments' Payments of Debt of €0 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Healthcare Plans company?
A good Payments of Debt depends on the Healthcare Plans industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Clover Health Investments and its competitors. Clover Health Investments's current Payments of Debt is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clover Health Investments stock overvalued right now?
Based on GuruFocus' analysis, Clover Health Investments (FRA:7QD) is currently considered Fairly Valued. The stock's GF Value™ is €3.67, compared to a current price of €3.90 — trading 6.3% above its estimated fair value. The current Payments of Debt is €0 Mil. Clover Health Investments' overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Clover Health Investments (FRA:7QD), the current Payments of Debt is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clover Health Investments (FRA:7QD) Overvalued in 2026?

Based on GuruFocus' analysis, Clover Health Investments stock appears to be overvalued. The current stock price of €3.90 is trading 6.3% above its estimated GF Value™ of €3.67. GuruFocus considers Clover Health Investments to be Fairly Valued.

Key valuation signals for FRA:7QD:

  • Payments of Debt: €0 Mil
  • GF Value™: €3.67 vs. price of €3.90 (6.3% above fair value)
  • GF Score™: 83/100 with 3 warning signs

No single metric tells the full story. See the FRA:7QD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clover Health Investments Business Description

Other Exchanges CLOV:USACLOV34:Brazil
Address 3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
83GF Score

Get the complete analysis for FRA:7QD

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.90
Price
€3.67
GF Value